New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding Jan. 31, 2022
Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model Jan. 31, 2022